Form 4: Doximity Director Kira Scherer Wampler Executes Stock Sales Under 10b5-1 Plan
SEC Form 4
Kira Scherer Wampler, a director at Doximity, Inc., executed multiple sales of Class A Common Stock on February 11, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On February 11, 2025, Kira Scherer Wampler, a director of Doximity, Inc., engaged in transactions involving the company's stock.
- Wampler converted 2,000 shares of Class B Common Stock into Class A Common Stock.
- She also sold 931 shares of Class A Common Stock at $76.1152 per share, 202 shares at $76.9935 per share, 767 shares at $78.1931 per share, and 100 shares at $79.95 per share.
- These sales were executed automatically under a Rule 10b5-1 trading plan adopted on November 12, 2024.
- Following these transactions, Wampler directly owns 16,618 shares of Class A Common Stock and 487,700 derivative securities related to Class B Common Stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing primarily reports stock sales under a pre-arranged plan, which doesn't inherently indicate positive or negative sentiment about the company's future.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It's common for executives and directors to utilize 10b5-1 trading plans to sell shares over time to avoid accusations of trading on inside information. The volume and frequency of these sales can be monitored by investors to gauge insider sentiment, but these sales are often pre-planned and don't necessarily reflect a change in the insider's view of the company's prospects.
Comparison to Industry Standards
- Insider selling is a common practice across publicly traded companies, particularly in the tech sector where stock-based compensation is prevalent.
- Comparing Wampler's transactions to those of other directors at similar companies (e.g., Teladoc, Veeva) would require analyzing their Form 4 filings for similar patterns of 10b5-1 plan usage and sale volumes.
- The impact of these sales on Doximity's stock price would depend on market conditions, overall investor sentiment, and the company's performance relative to its peers.
Stakeholder Impact
- The stock sales could have a minor impact on shareholders if they perceive it as a lack of confidence from a director, although the 10b5-1 plan mitigates this concern.
- Employees may be indirectly affected by any stock price fluctuations resulting from these transactions.
Key Dates
| Date | Description |
|---|---|
| 2020-03-27 | Stock option vested in 36 equal monthly installments after this date. |
| 2020-06-10 | Stock option grant date. |
| 2024-11-12 | Date the Reporting Person adopted the Rule 10b5-1 trading plan. |
| 2025-02-11 | Date of the reported transactions (stock conversion and sales). |
| 2025-02-13 | Date of the Form 4 filing. |
| 2030-06-09 | Expiration date of the stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.